期刊文献+

中国汉族儿童CYP3A5*3基因型与急性淋巴细胞白血病易感性的关联研究(英文) 被引量:1

Association of CYP3A5*3 with Acute Lymphoblastic Leukemia susceptiveness in Chinese Han children
下载PDF
导出
摘要 目的:在中国汉族儿童中探讨白血病易感性与CYP3A5*3的频率之间的相关性。方法:共收集172名中国汉族儿童血液,包括52名急性白血病患者(27女性,25男性)和120名健康儿童(53女性,67男性)。提取DNA,然后用PCR-RFLP方法检测基因型。结果:CYP3A5*3在人群中的分布符合Hardy-Weinberg平衡。儿童白血病中CYP3A5*3频率为0.721(95%CI:0.549,0.893),而健康儿童中为0.758(95%CI:0.674,0.842),两者之间无明显差异,并且也无男女性别差异。结论:CYP3A5*3是健康儿童和白血病患者中的常见基因型,健康儿童和白血病患儿中CYP3A5*3频率一致,因此CYP3A5*3与儿童白血病易感性之间无关联。 ABSTRACT To investigate the association of CYP3A5 * 3 with Acute Lymphoblastic Leukemia (ALL) susceptiveness in Chinese Han children. METHODS: CYP3A5 genotype was analyzed from 172 Chinese han children, including 52 ALL patients(27 female and 25 male) and 120 healthy controls(80 female and 92 male). Genomic DNA was extracted from blood sample, and PCR-RFLP was used to identify the polymorphism. RESULTS: This polymorphism were matched to HardyWeinberg equilibrium in all group. The allelic frequency of CYP3A5* 3 was 0. 721 (950//00 CI: 0. 549, 0. 893) in patients while 0.758 (95% CI: 0.674, 0.842) in healthy controis. There was no significant difference existed in CYP3A5* 3 frequencies between patients and controls (P=0. 275), males and females (P= 0. 432) in the total population. CONCLUSION: The CYP3A5* 3 variant represents a common polymorphism in Chinese healthy children andALL, and this polymorphism is poor association with ALL susceptiveness in children.
作者 刘艳 陆晓彤 盛琦 田怀平 徐阿晶 唐跃年 卜书红 李莉霞 张健 LIU Yan;LU Xiao-tong;SHENG Qi;TIAN Huai-ping;XU A-jing;TANG Yue-nian;BU Shu-hong;LI Li-xia;ZHANG Jian(Department of Pharmacy,Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine;Department of Pediatric Hematology and Oncology,Shanghai 200092,China)
出处 《中国临床药理学与治疗学》 CSCD 2012年第1期73-77,共5页 Chinese Journal of Clinical Pharmacology and Therapeutics
基金 Research Award Fund for out Standing Young Teachers of Shanghai Project suported by the Shanghai Health Bureau,China(2009068)
关键词 儿童急性淋巴细胞白血病(ALL) CYP3A5*3 遗传变异 Acute Lymphoblastic Leukemia(ALL) CYP3A5* 3 Polymorphism
  • 相关文献

参考文献23

  • 1Raunio H,Husgafvel-Pursiainen K,Anttila S,et al.Diagnosis of polymorphisms in carcinogen-acti-vating and inactivating enzymes and cancer suscepti-bility-a review[J].Gene,1995,159(1):113-121.
  • 2Perera FP.Molecular epidemiology:insights into cancer susceptibility,risk assessment,and preven-tion[J].J Natl Cancer Inst,1996,88(8):496-509.
  • 3Wilkinson GR.Drug metabolism and variability a-mong patients in drug response[J].N Engl J Med,2005,352(21):2211-2221.
  • 4Lamba JK,Lin YS,Schuetz EG,et al.Genetic con-tribution to variable human CYP3A-mediated me-tabolism[J].Adv Drug Deliv Rev,2002,54(10):1271-1294.
  • 5Wojnowski L.Genetics of the variable expression of CYP3Ain humans[J].Ther Drug Monit,2004,26(2):192-199.
  • 6张松波,段娟,闾四平,尚云峰,宋旭日,周宏灏.天然维生素E对CYP3A4活性影响的体内研究[J].中国临床药理学与治疗学,2010,15(8):911-915. 被引量:4
  • 7李晓宇,刘皋林.CYP450酶特性及其应用研究进展[J].中国临床药理学与治疗学,2008,13(8):942-946. 被引量:53
  • 8Xie HG,Wood AJ,Kim RB,et al.Genetic varia-bility in CYP3A5and its possible consequences[J].Pharmacogenomics,2004,5(3):243-272.
  • 9Van Schaik RH,van der Heiden IP,van den Anker JN,et al.CYP3A5variant allele frequencies in Dutch Caucasians[J].Clin Chem,2002,48(10):1668-1671.
  • 10Kim KA,Park PW,Lee OJ,et al.Effect of CYP3A5*3genotype on the pharmacokinetics and pharmacodynamics of amlodipine in healthy Korean suhjects[J].Clin Pharmacol Ther,2006,80(6):646-656.

二级参考文献32

  • 1赵伟红,陈枢青.细胞色素P4502C19基因多态性的研究进展[J].宁波大学学报(理工版),2004,17(2):230-233. 被引量:3
  • 2陈騉,王睿.药物代谢酶细胞色素P4502C9研究进展[J].中国临床药理学与治疗学,2004,9(6):601-606. 被引量:15
  • 3高晓新,梁爱华,郑素勤.中草药对细胞色素P450酶系影响的研究进展[J].中国实验方剂学杂志,2006,12(9):64-67. 被引量:14
  • 4成碟,徐为人,刘昌孝.细胞色素P450(CYP450)遗传多态性研究进展[J].中国药理学通报,2006,22(12):1409-1414. 被引量:44
  • 5Landes N, Pfluger P, Kluth D,et al. Vitamin E activates gene expression via the pregnane X receptor [J]. BiochemPharmaeol, 2003,65(2):269--273.
  • 6Mustacich DJ, Leonard SW, Devereaux MW, et al. α- Toeopherol regulation of cytochrome P450s and ABC transporters in rats[J]. Free Radical Biol Med, 2006,41(7):1069 -1078.
  • 7Leonard SW, Paterson E, Atkinson JK, et al. Studies in humans using deuterium labeled alpha- and gamma-tocopherols demonstrate faster plasma gamma-tocopherol disappearance and greater gamma-metabolite production[J]. Free Radic Biol Med, 2005,38(7) :857--866.
  • 8Cheung MC, Zhao XQ, Chair A, et al. Antioxidant supplements block the response of HDL to simvastatin niacin therapy in patients with coronary artery disease and low HDL [J]. Arterioseler Thromb Vasc Biol, 2001,21 (8):1320--1326.
  • 9Brown BG, Zhao XQ, Chait A, et al. Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease[J]. N Engl J Med, 2001,345 (22) : 1583--1592.
  • 10Prueks T,Gorham LM,Liu L,et al. In vitro metabolism of simavastatin in humans identification of metabolizing enzymes and effect of the drug on hepatic P450s [J]. Drug MetabDispos,1997,25 (10) :1191 --1199.

共引文献55

同被引文献3

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部